Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

BKV ORATION ($BKV) Releases Q1 2026 Earnings

None

BKV ORATION ($BKV) posted quarterly earnings results for Q1 2026 on Thursday, May 7th. The company reported earnings of $0.22 per share, missing estimates of $0.52 by $0.30. The company also reported revenue of $379,740,000, beating estimates of $349,265,211 by $30,474,789.

You can see Quiver Quantitative's $BKV stock page to track data on insider trading, hedge fund activity, congressional trading, and more.

BKV ORATION Insider Trading Activity

BKV Insider Trades

BKV ORATION insiders have traded $BKV stock on the open market 8 times in the past 6 months. Of those trades, 0 have been purchases and 8 have been sales.

Here’s a breakdown of recent trading of $BKV stock by insiders over the last 6 months:

  • CHRISTOPHER P KALNIN (Chief Executive Officer) has made 0 purchases and 5 sales selling 400,000 shares for an estimated $11,137,748.
  • ERIC S JACOBSEN (President, Upstream) sold 25,000 shares for an estimated $773,895
  • DAVID TAMERON (Chief Financial Officer) sold 7,300 shares for an estimated $216,918
  • LINDSAY B LARRICK (Chief Legal and Admin Officer) sold 6,518 shares for an estimated $162,950

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.

BKV ORATION Hedge Fund Activity

We have seen 113 institutional investors add shares of BKV ORATION stock to their portfolio, and 38 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.

BKV ORATION Analyst Ratings

Wall Street analysts have issued reports on $BKV in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • Mizuho issued a "Outperform" rating on 12/12/2025
  • Barclays issued a "Overweight" rating on 11/13/2025

To track analyst ratings and price targets for BKV ORATION, check out Quiver Quantitative's $BKV forecast page.

BKV ORATION Price Targets

Multiple analysts have issued price targets for $BKV recently. We have seen 9 analysts offer price targets for $BKV in the last 6 months, with a median target of $35.0.

Here are some recent targets:

  • Lloyd Byrne from Jefferies set a target price of $35.0 on 04/15/2026
  • Stephen Richardson from Evercore ISI Group set a target price of $33.0 on 04/06/2026
  • Tim Rezvan from Keybanc set a target price of $35.0 on 04/02/2026
  • Gabe Daoud from Truist Securities set a target price of $37.0 on 03/24/2026
  • Scott Gruber from Citigroup set a target price of $36.0 on 03/10/2026
  • Leo Mariani from Roth Capital set a target price of $31.0 on 01/07/2026
  • Nitin Kumar from Mizuho set a target price of $36.0 on 12/12/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles